|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 38/28 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Number of the document | 3630164 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18730908.3 |
| Date of filing the European patent application | 2018-05-24 | |
| (97) | Date of publication of the European application | 2020-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation | 2023-10-25 |
| (86) | Number | PCT/US2018/034278 |
| Date | 2018-05-24 |
| (87) | Number | WO 2018/222472 |
| Date | 2018-12-06 |
| (30) | Number | Date | Country code |
| 201762513556 P | 2017-06-01 | US |
| (72) |
BOTROS, Fady Talaat , US
LAKSHMANAN, Mark Chandrakant , US
TUTTLE, Katherine Rose , US
ZIMMERMANN, Alan George , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Jelena GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Dulagliutidas, skirtas lėtinės inkstų ligos gydymui |
| DULAGLUTIDE FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 8 | 185.00 EUR |
| 2026-05-24 |